547
Views
10
CrossRef citations to date
0
Altmetric
Articles

Serious Adverse Events Reported with Dietary Supplement Use in the United States: A 2.5 Year Experience

, , , &
Pages 227-248 | Received 23 Apr 2018, Accepted 13 Aug 2018, Published online: 04 Dec 2018

References

  • Abdollahi M, Farshchi A, Nikfar S, Seyedifar M. 2013. Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J Pharm Pharm Sci. 16(1):99–114.
  • Al-Halawani MZ, Thawabi M, Asslo F, Shaaban H, Shamoon F, Baddoura WJ. 2014. Losartan-induced ischemic hepatocellular hepatotoxicity: a case report and literature review. J Family Med Prim Care. 3(3):272–274.
  • Alvarez-Sabin J, Ortega G, Jacas C, Santamarina E, Maisterra O, Ribo M, Molina C, Quintana M, Roman GC. 2013. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis. 35(2):146–154.
  • Arinzon Z, Alexander P, Berner Y. 2004. Hydrochlorothiazide induced hepato-cholestatic liver injury. Age Ageing. 33(5):509–510.
  • Ashar BH, Rice TN, Sisson SD. 2007. Physicians' understanding of the regulation of dietary supplements. Arch Intern Med. 167(9):966–969.
  • Bilal M, Patel Y, Burkitt M, Babich M. 2015. Linoleic acid induced acute hepatitis: a case report and review of the literature. Case Reports Hepatol. 2015;807354.
  • Brown AC. 2017. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food Chem Toxicol. 107(Pt A):449–471.
  • Cellini M, Attipoe S, Seales P, Gray R, Ward A, Stephens M, Deuster PA. 2013. Dietary supplements: physician knowledge and adverse event reporting. Med Sci Sports Exerc. 45(1):23–28.
  • Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. 2015. Polypharmacy among adults aged 65 years and older in the United States: 1988-2010. J Gerontol A Biol Sci Med Sci. 70(8):989–995.
  • Chen SC, Lin YH, Huang HP, Hsu WL, Houng JY, Huang CK. 2012. Effect of conjugated linoleic acid supplementation on weight loss and body fat composition in a Chinese population. Nutrition. 28(5):559–565.
  • Council for Responsible Nutrition. 2017. Dietary supplement usage increases, says new survey. Available from https://www.crnusa.org/newsroom/dietary-supplement-usage-increases-says-new-survey [last accessed 2018 Jul 24].
  • Davis PA, Yokoyama W. 2011. Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food. 14(9):884–889.
  • Dickinson A, MacKay D. 2014. Health habits and other characteristics of dietary supplement users: a review. Nutr J. 13;14.
  • Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. 2014. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 13(2):227–239.
  • AER Law. 2006. Dietary Supplement and Non-Prescription Consumer Protection Act (AER Law). Pub. Law No. 109–462 (Dec. 22, 2006).
  • Dietary Supplement Health and Education Act 1994. Public Law No. 103-417 (Oct. 25, 1994).
  • Doron S, Snydman DR. 2015. Risk and safety of probiotics. Clin Infect Dis. 60(suppl_2):S129–S134.
  • Edridge CL, Dunkley AJ, Bodicoat DH, Rose TC, Gray LJ, Davies MJ, Khunti K. 2015. Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One. 10(6):e0126427
  • Food, Drug & Cosmetic Act. 2006. 21 U.S.C. Part H, Section 761, 379aa-1. p. 377–379.
  • Gilmour J, Harrison C, Asadi L, Cohen MH, Vohra S. 2011. Natural health product-drug interactions: evolving responsibilities to take complementary and alternative medicine into account. Pediatrics. 128(Supplement 4):S155–S160.
  • GlobalRPh 2018. Selected warfarin drug-drug interactions. [accessed 2018 Jul 24]. http://www.globalrph.com/warfarin_drug_interactions.htm.
  • Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, Guyatt GH, Johnston BC. 2013. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013:CD006095.
  • Hashiguchi M, Ohta Y, Shimizu M, Maruyama J, Mochizuki M. 2015. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. J Pharm Health Care Sci. 114
  • Hazell L, Shakir SA. 2006. Under-reporting of adverse drug reactions : a systematic review. Drug Saf. 29(5):385–396.
  • Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. 2016. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Int J Cardiovasc Imaging. 32(1):49–59.
  • Hruby A, Hu FB. 2015. The epidemiology of obesity: a big picture. Pharmacoeconomics. 33(7):673–689.
  • Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, Guyatt GH. 2012. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 157(12):878–888.
  • Kamenova P. 2006. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens)). 5(4):251–258.
  • Kanji S, Seely D, Yazdi F, Tetzlaff J, Singh K, Tsertsvadze A, Tricco AC, Sears ME, Ooi TC, Turek MA, et al. 2012. Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review. Syst Rev. 126
  • Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. 2016. Trends in dietary supplement use among US adults from 1999-2012. JAMA. 316(14):1464–1474.
  • Khurshid S, Choi SH, Weng LC, Wang EY, Trinquart L, Benjamin EJ, Ellinor PT, Lubitz SA. 2018. Frequency of cardiac rhythm abnormalities in a half million adults. Circ Arrhythm Electrophysiol. 11(7):e006273.
  • Klemenc-Ketis Z, Krizmaric M, Kersnik J. 2013. Age- and gender-specific prevalence of self-reported symptoms in adults. Cent Eur J Public Health. 21(3):160–164.
  • Klontz KC, DeBeck HJ, LeBlanc P, Mogen KM, Wolpert BJ, Sabo JL, Salter M, Seelman SL, Lance SE, Monahan C, et al. 2015. The role of adverse event reporting in the FDA response to a multistate outbreak of liver disease associated with a dietary supplement. Public Health Rep. 130(5):526–532.
  • Kothadia JP, Kaminski M, Samant H, Olivera-Martinez M. 2018. Hepatotoxicity associated with use of the weight loss supplement Garcinia cambogia: a case report and review of the literature. Case Reports Hepatol. 20186483605
  • Lehnen TE, da Silva MR, Camacho A, Marcadenti A, Lehnen AM. 2015. A review on effects of conjugated linoleic fatty acid (CLA) upon body composition and energetic metabolism. J Int Soc Sports Nutr. 1236
  • Levinson DR. 2012. Hospital incident reporting systems do not capture most patient harm. Report OEI-06-09-00091. Washington (DC): Department of Health and Human Services, Office of Inspector General.
  • Liu Q, Sikand P, Ma C, Tang Z, Han L, Li Z, Sun S, LaMotte RH, Dong X. 2012. Mechanisms of itch evoked by β-alanine. J Neurosci. 32(42):14532–14537.
  • Lu T, Sheng H, Wu J, Cheng Y, Zhu J, Chen Y. 2012. Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res. 32(6):408–412.
  • Lunsford KE, Bodzin AS, Reino DC, Wang HL, Busuttil RW. 2016. Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation. World J Gastroenterol. 22(45):10071–10076.
  • Makam RC, Erskine N, McManus DD, Lessard D, Gore JM, Yarzebski J, Goldberg RJ. 2016. Decade-long trends (2001 to 2011) in the use of evidence-based medical therapies at the time of hospital discharge for patients surviving acute myocardial infarction. Am J Cardiol. 118(12):1792–1797.
  • MarketData Enterprises 2015. The US weight loss market: 2015 status report & forecast. Tampa (FL): MarketData Enterprises.
  • MedDRA 2018. MedDRA: Medical Dictionary for Regulatory Activities. [accessed 2018 Jul 30]. https://meddra.org.
  • Merck 2018. Simvastatin prescribing information. [accessed 2018 Mar 4]. https://www.merck.com/product/usa/pi_circulars/z/zocor/zocor_pi.pdf.
  • Misaka S, Yatabe J, Muller F, Takano K, Kawabe K, Glaeser H, Yatabe MS, Onoue S, Werba JP, Watanabe H, et al. 2014. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther. 95(4):432–438.
  • Murtaza G, Ullah N, Mukhtar F, Nawazish S, Muneer S. 2017. Phytotherapeutics: the emerging role of intestinal and hepatocellular transporters in drug interactions with botanical supplements. Molecules. 22(10):E1699.
  • Nortadas R, Barata J. 2012. Fulminant hepatitis during self-medication with conjugated linoleic acid. Ann Hepatol. 11(2):265–267.
  • Papanas N, Ziegler D. 2014. Efficacy of α-lipoic acid in diabetic neuropathy . Expert Opin Pharmacother. 15(18):2721–2731.
  • Park SH, Ishino R. 2013. Liver injury associated with antidepressants. Curr Drug Saf. 8(3):207–223.
  • Peng X, Zhou R, Wang B, Yu X, Yang X, Liu K, Mi M. 2014. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep. 46251
  • Preuss HG, Rao CV, Garis R, Bramble JD, Ohia SE, Bagchi M, Bagchi D. 2004. An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management. J Med. 35(1-6):33–48.
  • Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS. 2011. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 76(16):1389–1394.
  • Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. 2016. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 4(13):256
  • Schmitz SM, Lopez HL, MacKay D. 2014. Nutravigilance: principles and practices to enhance adverse event reporting in the dietary supplement and natural products industry. Int J Food Sci Nutr. 65(2):129–134.
  • Scondotto G, Pojero F, Pollina Addario S, Ferrante M, Pastorello M, Visconti M, Scondotto S, Casuccio A. 2018. The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy. Aging Clin Exp Res. 30(1):81–87.
  • Semwal RB, Semwal DK, Vermaak I, Viljoen A. 2015. A comprehensive scientific overview of Garcinia cambogia. Fitoterapia. 102134–148.
  • Singhal K, Raj N, Gupta K, Singh S. 2017. Probable benefits of green tea with genetic implications. J Oral Maxillofac Pathol. 21(1):107–114.
  • Stellingwerff T, Anwander H, Egger A, Buehler T, Kreis R, Decombaz J, Boesch C. 2012. Effect of two β-alanine dosing protocols on muscle carnosine synthesis and washout . Amino Acids. 42(6):2461–2472.
  • Tan MS, Yu JT, Tan CC, Wang HF, Meng XF, Wang C, Jiang T, Zhu XC, Tan L. 2015. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis. 43(2):589–603.
  • Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. 2017. The safety of ingested caffeine: a comprehensive review. Front Psychiatry. 880
  • Teschke R, Andrade RJ. 2016. Drug, herb, and dietary supplement hepatotoxicity. IJMS. 17(9):1488.
  • Teschke R, Eickhoff A. 2016. The Honolulu liver disease cluster at the medical center: its mysteries and challenges. Int J Mol Sci. 17(4):476
  • Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. 2013. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol. 25(9):1093–1098.
  • Timbo BB, Chirtel SJ, Ihrie J, Oladipo T, Velez-Suarez L, Brewer V, Mozersky R. 2018. Dietary supplement adverse event report data from the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013. Ann Pharmacother. 52(5):431–438.
  • Tomlinson LA, Holt SG, Leslie AR, Rajkumar C. 2009. Prevalence of ambulatory hypotension in elderly patients with CKD stages 3 and 4. Nephrol Dial Transplant. 24(12):3751–3755.
  • Tsai HH, Lin HW, Simon Pickard A, Tsai HY, Mahady GB. 2012. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. Int J Clin Pract. 66(11):1056–1078.
  • Walenga JM, Adiguzel C. 2010. Drug and dietary interactions of the new and emerging oral anticoagulants. Int J Clin Pract. 64(7):956–967.
  • Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K, Squellerio I, Laguzzi F, Onoue S, Veglia F, et al. 2015. Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des. 21(9):1213–1219.
  • Xu ZQ, Liang XM, Juan W, Zhang YF, Zhu CX, Jiang XJ. 2012. Treatment with huperzine A improves cognition in vascular dementia patients. Cell Biochem Biophys. 62(1):55–58.
  • Yoon SL, Schaffer SD. 2006. Herbal, prescribed, and over-the-counter drug use in older women: prevalence of drug interactions. Geriatr Nurs. 27(2):118–129.
  • Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, et al. 2010. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metab Clin Exp. 59(2):285–292.
  • Zhang XL, Chen M, Zhu LL, Zhou Q. 2017. Therapeutic risk and benefits of concomitantly using herbal medicines and conventional medicines: from the perspectives of evidence based on randomized controlled trials and clinical risk management. Evid Based Complement Alternat Med. 20179296404

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.